Filing Details

Accession Number:
0001123292-15-001368
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-24 20:01:53
Reporting Period:
2015-11-23
Filing Date:
2015-11-24
Accepted Time:
2015-11-24 20:01:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437786 Immune Design Corp. IMDZ Pharmaceutical Preparations (2834) 262007174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1605922 Wayne Gombotz C/O Immune Design Corp.
1616 Eastlake Ave. E., Suite 310
Seattle WA 98102
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-23 5,000 $1.31 5,034 No 4 M Direct
Common Stock Disposition 2015-11-23 5,000 $20.00 34 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-11-23 5,000 $0.00 5,000 $1.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,715 2021-12-08 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2015.
  2. One quarter of the shares underlying the option vested on December 1, 2012, and the remainder of the shares underlying the option vest at a rate of 1/36th per month thereafter.